Ottawa, Dec. 06, 2024 (GLOBE NEWSWIRE) -- The global ophthalmic packaging market size is predicted to increase from USD 7.93 billion in 2025 to approximately USD 15.89 billion by 2034, According to Precedence Research. The North America ophthalmic packaging market size was estimated at USD 2.70 billion in 2024.
The Full Study is Readily Available | Download the Sample Pages of this Report@ https://www.precedenceresearch.com/sample/3072
The pharmaceutical industry is always changing, and ocular medicine is one of the most delicate but difficult fields. Because these goods are meant to cure eye conditions, their packaging needs to be extremely specific in order to guarantee their longevity, safety, and effectiveness. In addition to serving as a product wrapper, packaging for eye medications is an important factor that can have a direct impact on the standard of care. For ophthalmic medications, there are several packaging options, each with unique features to satisfy various drug and patient requirements. Pharmaceutical businesses package ophthalmic medications using a variety of materials and techniques.
Ophthalmic Packaging Market Key Highlights:
- North America led the ophthalmic packaging market and contributed the largest market share of 36.85% in 2023.
- Asia Pacific is expected to grow at a solid CAGR of 8.8% from 2024 to 2034.
- By Application, the prescription segment accounted for the largest market share of 56.89% of in 2023.
- By Material, the plastic segment generated the biggest market share of 53.84% in 2023.
Immediate Delivery Available | Buy This Premium Research Report@ https://www.precedenceresearch.com/checkout/3072
Growth Factors in Ophthalmic Packaging Market
- Environmental sustainability: Packaging solutions that are more ecologically friendly, including using recyclable materials or materials sourced from sustainable sources, have been developed as a result of the growing emphasis on environmental effects. However, the requirement to uphold strict safety and sterility regulations must be balanced with the adoption of eco-friendly materials.
- Smart technologies: The use of smart devices in eye packaging is becoming a more intriguing trend. By monitoring proper drug usage, warning patients of prescription mistakes, or reminding them to take their dosages, these devices help improve treatment adherence.
- Growing ophthalmic diseases: Eye care medications are necessary for the effective treatment of certain ophthalmic conditions and eye irritations. Among the major reasons for developing eye problems include diabetes and age-related conditions.
Opportunities in the Ophthalmic Packaging Market
- In October 2024, the commercial launch of Qlosi™ (pilocarpine hydrochloride ophthalmic solution) 0.4%, a new corrective eye drop for the treatment of adult presbyopia, will be supported by a $78 million funding deal, according to Orasis Pharmaceuticals.
- In August 2024, Ocumension Therapeutics and Alcon Inc. announced an arrangement wherein Ocumension would purchase or get the rights to commercialize a portfolio of Alcon dry eye therapies and procedural drops in China. This partnership includes a number of commercially accessible medications as well as one product that is still in the development stage. When these rights are transferred, OcuMension will give Alcon 139,161,120 shares, which will represent 16.71% of the entire share capital (post-issuance).
Ophthalmic Packaging Market Regional Outlook
U.S. Ophthalmic Packaging Market Size and Forecast 2024 to 2033
The U.S. ophthalmic packaging market size is estimated at USD 1.67 billion in 2024 and is predicted to hit around USD 3.40 billion by 2034, growing at a CAGR of 7.5% from 2024 to 2034.
Growing Investment in Healthcare, North America to Sustain as a Leader
North America dominated the ophthalmic packaging market in 2023. The variables that drive market demand include the implementation of stringent regulatory regulations in parametrical packing, the expanding export of ophthalmic goods, and the rising prevalence of ocular illnesses. In addition, the packing industry's strong need for plastics, such as simple molding, temperature and weather resistance, and the capacity to take on the necessary form, make North America one of the biggest users of plastics internationally.
Additionally, rising R&D expenditures in the healthcare industry, as well as the aging population, increase sector demand. In North America, these variables, therefore, generate a profitable market for ophthalmic packaging.
In the United States alone, around 12 million adults over 40 have some form of visual impairment, and approximately one million are blind. Statistics from the World Health Organization indicate that over 2.2 billion individuals worldwide suffer from eye and visual issues. Over 14.2 million persons over 40, or 8.4 percent of the population, suffer from farsightedness. Nearsightedness affects around 34 million persons over 40, or 23.9% of the population.
According to the Government of Canada, the total amount of money invested in vision medical research in Canada is projected to reach $26.2 million in 2023, up 23% from 2021 ($21.3 million) and 25% from 2019 ($20.9 million).
Government Support in Asian Countries to Expand the Market’s Presence
Asia Pacific is expected to host the fastest-growing ophthalmic packaging market during the forecast period. Both governmental and non-governmental measures, such as national healthcare programs and ocular screening, would expand access to ophthalmic healthcare. Furthermore, policies like the "economic free trade zone" and shorter permission times for the establishment of creative ophthalmic manufacturing facilities would accelerate market expansion.
Also, developing nations like China and India are expected to witness rapid development in the ophthalmology sector. The global market is currently facing a number of obstacles, such as market saturation, patent expiration, and strict regulations. Nevertheless, the growing population, increased emphasis on longer life expectancies, and rising disposable income will present these players with significant growth prospects.
The most prevalent eye condition in the world is myopia, which affects 25–50% of adults in the US and Europe and up to 85–90% of young individuals in Asian nations. Myopia advances remarkably quickly in East Asia throughout childhood, and by maturity, roughly 24% of individuals may have extreme myopia.
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
Ophthalmic Packaging Market Report Coverage
| Report Attribute | Key Statistics |
| Growth Rate from 2024 to 2034 | CAGR of 8.2% |
| Market Size in 2024 | USD 7.35 Billion |
| Market Size by 2034 | USD 15.89 Billion |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2023 |
| Forecast Period | 2024 to 2034 |
| Segments Covered | By Material, By Product Type, and By Application |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Ophthalmic Packaging Market Segmentation Outlook
By Application Outlook
The prescription medication segment held the dominant share of the ophthalmic packaging market in 2023. Because medications applied to the eyes circumvent some of the body's natural defenses, ophthalmic medicine products, such as eye drops, provide a higher risk of injury to consumers. For a variety of reasons, prescription eye drops could be a better choice. Prescription eye drops are made especially to address certain eye disorders. Although side effects are a possibility with any treatment, prescription eye drops usually have fewer and milder adverse effects than over-the-counter drops.
By Material Outlook
The plastic segment captured the major share of the ophthalmic packaging market in 2023. Ophthalmic products are most frequently packaged in plastic bottles, which are typically composed of low-density polyethylene (LDPE), polypropylene (PP), high-density polyethylene (HDPE), and other materials based on the particular needs of the product. Plastic is a very adaptable material that is used extensively in many industries, including the pharmaceutical sector, to create packaging solutions because of its mechanical strength, flexibility, and stability.
Browse More Insights:
- Pharmaceutical Packaging Market: The global pharmaceutical packaging Market size was USD 134.07 billion in 2023, estimated at USD 146.14 billion in 2024 and is anticipated to reach around USD 342.16billion by 2034, expanding at a CAGR of 8.88% from 2024 to 2034.
- Pharmaceutical Temperature Controlled Packaging Solutions Market: The global pharmaceutical temperature controlled packaging solutions market size reached USD 5.53 billion in 2023 and is expected to hit around USD 10.8 billion by 2033, poised to grow at a CAGR of 6.9% from 2024 to 2033.
- Temperature Controlled Packaging Solutions Market: The global temperature controlled packaging solutions market size was valued at USD 13.90 billion in 2023 and is projected to reach around USD 33.78 billion by 2033, poised to grow at a CAGR of 9.28% during the forecast period 2024 to 2033.
- Pharmaceutical Contract Packaging Market: The global pharmaceutical contract packaging market size was USD 12.99 billion in 2023, estimated at USD 14.16 billion in 2024 and is anticipated to reach around USD 29.76 billion by 2034, expanding at a CAGR of 7.71% from 2024 to 2034.
- Sustainable Pharmaceutical Packaging Market: The global sustainable pharmaceutical packaging market size surpassed USD 87.29 billion in 2023 and is estimated to increase from USD 99.70 billion in 2024 to approximately USD 376.82 billion by 2034. It is projected to grow at a CAGR of 14.22% from 2024 to 2034.
- Medical Device Packaging Market: The global medical device packaging market size was estimated at USD 32.6 billion in 2021 and projected to surpass around USD 63.1 billion by 2030, recording a compound annual growth rate (CAGR) of 7.61% during the forecast period 2022 to 2030.
- Clinical Trial Packaging Market: The global clinical trial packaging market size was estimated at USD 2.7 billion in 2022 and it is expected to reach around USD 7.43 billion by 2032 and poised to grow at a compound annual growth rate (CAGR) of 10.7% during the forecast period 2023 to 2032.
- Antimicrobial Packaging Market: The global antimicrobial packaging market size is expected to be worth around USD 14.39 billion by 2032 valued at USD 8 billion by 2022 and expanding growth at a compound annual growth rate (CAGR) of 6.1% during the forecast period 2023 to 2032.
- Healthcare Packaging Market: The global healthcare packaging market size accounted for USD 138.82 billion in 2023 and is expected to hit around USD 207.52 billion by 2033 and is poised to grow at a CAGR of 4.15% over the forecast period 2024 to 2033.
- Ophthalmic Sutures Market: The global ophthalmic sutures market size was valued at USD 577.16 million in 2023 and is anticipated to reach around USD 1,120.60 million by 2033, growing at a CAGR of 6.86% from 2024 to 2033.
Ophthalmic Packaging Market Top Companies
- Amcor
- West Pharmaceutical Services, Inc.
- Gerresheimer AG
- SCHOTT AG
- AptarGroup, Inc.
- Akorn, Inc.
- Johnson & Johnson Vision
- Mitotech, SA
- Bausch & Lomb Incorporated
- AERIE PHARMACEUTICALS, INC.
- Novartis AG
- Merck Sharp & Dohme Corp.
- Bayer AG
- F. Hoffmann-La Roche Ltd.
- ALLERGAN
- Santen Pharmaceutical Co.
- Teva Pharmaceutical Industries Ltd.
* Interested in Company Profiles? Connect with Us for Detailed Profiles
- In September 2024, Naphazoline hydrochloride is the newest active pharmaceutical ingredient (API) from C2 PHARMA, a worldwide supplier of ophthalmic and specialty APIs. In June 2024, the Naphazoline HCL validation effort was finished. While the US-Drug Master File (US-DMF) is scheduled to be submitted by November 2024 and the API dossier for Brazil (DIFA) by December 2024, a Certificate of Suitability (CEP) is now pending clearance.
What is Going Around the Globe?
- In November 2024, Berry Global introduced the "easy squeeze" 10ml ophthalmic container, which is designed for the Aptar Pharma ocular squeeze dispenser (OSD), which is used for eye treatments and other goods without preservatives.
- In July 2023, Alkem Laboratories, located in India, declared that it is entering the ophthalmology market by introducing a line of eye care products.
Segments Covered in the Report
By Application
- Prescription Medication
- OTC Products
- Medical Devices
By Material
- Plastic
- Metal
- Glass
By Product Type
- Bottles & Vials
- Blister Packs
- Ampoules
- Squeezable Tubes
By Region
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East and Africa (MEA)
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or Asia Pacific.
Immediate Delivery Available | Buy This Premium Research Report@ https://www.precedenceresearch.com/checkout/3072
You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com | +1 804 441 9344
About Us
Precedence Research is a worldwide market research and consulting organization. We give an unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.
Web: https://www.precedenceresearch.com
Our Blogs:
https://www.towardshealthcare.com
https://www.towardspackaging.com
https://www.towardsevsolutions.com
Get Latest News:
https://www.precedenceresearch.com/news
For Latest Update Follow Us:
